The prognosis of idiopathic generalized epilepsy
Udaya Seneviratne, Mark Cook, Wendyl D'Souza
Epilepsia | WILEY | Published : 2012
Dr Seneviratne reports no disclosures. Professor Cook has received speaker honoraria from UCB Pharma and Sanofi Australia and travel honoraria from UCB Pharma and SciGen. He has received research grants from National Health and Medical Research Council (Australia), and Australian Research Council. He has also received a Science, Technology, and Innovation Grant from the State Government of Victoria, Australia. A/Professor D'Souza has received travel, investigator-initiated, and speaker honoraria from UCB Pharma, educational grants from Novartis Pharmaceuticals and Pfizer Pharmaceuticals, educational, travel and fellowship grants from GSK Neurology Australia, and honoraria from SciGen Pharmaceuticals. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.